Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.
Mar Tintoré(Vall d'Hebron Hospital Universitari), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Àlex Rovira(Centre National de la Recherche Scientifique), Cecilia Borrás(Hebron University), Luís Brieva(Hebron University), Jordi Río(Universitat Autònoma de Barcelona), María Jesús Martinez(Hebron University), Jaume Capellades(Hebron University), Elisenda Grivé(Hebron University), Pablo Villoslada(University of California, San Francisco)
PubMed
April 1, 2000
Cited by 428
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k